3.023USD-0.30%Mkt Cap: 586.34M USDP/E: —Last update: 2026-06-01
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap586.34M USD
Enterprise Value297.45M USD
Revenue (TTM)36.00K USD
Gross Profit-66.05M USD
Net Income (TTM)-88.09M USD
Revenue/Share0.0000 USD
Last Price3.023 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees57
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS02155H2004
Valuation
P/E (Trailing)—
P/E (Forward)-3.38
PEG32.62
EV/EBITDA-3.10
EV/Revenue8262.59
P/S16476.28
P/B1.40
EPS (TTM)-0.92
EPS (Forward)-0.90
52W Range
2.5609% of range7.730
52W High7.730 USD
52W Low2.560 USD
Profitability
Gross Margin0.00%
Oper. Margin-267247.22%
EBITDA Margin0.00%
Profit Margin-214860.98%
ROE-39.17%
ROA-31.47%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-67.53M USD
CapEx (TTM)11.00K USD
FCF Margin-118061.11%
FCF Yield-7.25%
Net Debt-295.69M USD
Net Debt/EBITDA3.08
Balance Sheet
Debt/Equity0.16
Current Ratio29.56
Quick Ratio29.43
Book Value/Sh2.181 USD
Cash/Share1.705 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJan 20, 2017
Pay DateSep 14, 2018
Splits
Last Split1:30
Split DateSep 14, 2018
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)16.06 USD
Target Range2.500 USD – 28.00 USD
# Analysts9
Ownership
Shares Out.194.47M
Float164.20M
Insiders0.40%
Institutions57.82%
Short Interest
Short Ratio7.2d
Short % Float19.38%
Short % Out.19.35%
Shares Short37.64M
Short (prev mo.)28.73M
Technical
SMA 503.116 (-3.0%)
SMA 2003.955 (-23.6%)
Beta0.17
S&P 52W Chg27.94%
Avg Vol (30d)4.52M
Avg Vol (10d)2.66M
Technical Indicators
RSI (14)50.5
MACD-0.0472
MACD Signal-0.0816
MACD Hist.+0.0344
BB Upper3.233 USD
BB Middle2.975 USD
BB Lower2.717 USD
BB Width17.32%
ATR (14)0.1503 USD
Vol Ratio (20d)0.37x